Clinical Trials Browser

Phase 2 × Vomiting × Radiotherapy, Intensity-Modulated × Clear all

NCT00895245 2017-05-18

Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Phase 2 Terminated

6 enrolled 5 charts

Squamous Cell Carcinoma of Head and Neck, Nausea, Vomiting